Tag Archives: biopharmaceuticals

New data from AstraZeneca’s renal medicines will be presented at the 57th European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) Virtual Congress

(PRESS RELEASE) CAMBRIDGE, 5-Jun-2020 — /EuropaWire/ — British-Swedish multinational pharmaceutical and biopharmaceutical company AstraZeneca announced it will present new data across continuum of care from its broad renal portfolio during the 57th virtual congress of the European Renal Association – … Read the full press release

SGS welcomes Edward R. Zartler, Ph.D as head of its biologics business across the United States

(PRESS RELEASE) GENEVA, 29-May-2020 — /EuropaWire/ — Leading bio/pharmaceutical analytical and bioanalytical contract solutions provider SGS announces the appointment of Edward R. Zartler, Ph.D as Director of Biopharmaceutical Services (USA). Edward, who joined SGS in May 2020, takes responsibility for … Read the full press release

PDA Announces Six Regulatory Authorities Speaking at Biomanufacturing in Munich

(PRESS RELEASE) BERLIN, 14-Aug-2019 — /EuropaWire/ — The Parenteral Drug Association (PDA) today announced representatives of seven health authorities have been invited to speak at the 2019 PDA Europe Biomanufacturing Conference, 3-4 September 2019 in Munich, Germany. The following health … Read the full press release

PDA Explores the Transformation of Healthcare at 4th Annual European Meeting

PDA Explores the Transformation of Healthcare at 4th Annual European Meeting

EMA, MHRA and FDA among regulatory agencies participating (PRESS RELEASE) BERLIN, 10-Jun-2019 — /EuropaWire/ — The Parenteral Drug Association (PDA) is excited to host its 4th Annual European Meeting: Global Healthcare of the Present and the Future, June 25-26 in … Read the full press release

EQT Credit supports Keensight Capital and ERES’ investment in Biovian

STOCKHOLM, 04-Jun-2018 — /EuropaWire/ — EQT Credit, through its Mid-Market investment strategy, is pleased to announce that it has provided the financing to support Keensight Capital and ERES’ (the “Shareholders”) investment in Biovian (or the “Company”), a leading European player in … Read the full press release

Wacker Chemie AG to acquire Dutch site for manufacturing biopharmaceuticals, live microbial products and vaccines from SynCo Bio Luxembourg S.à.r.l.

WACKER TAKES OVER SYNCO BIO PARTNERS OF AMSTERDAM CAPACITY OF ACQUIRED FERMENTATION PLANT FOR PHARMACEUTICAL ACTIVES TOTALS SOME 2,000 LITERS – WACKER BIOTECH’S OVERALL CAPACITY DOUBLES AS A RESULT SYNCO’S EXPERTISE IN MANUFACTURING LIVE MICROBIAL PRODUCTS AND IN FILLING FINISHED … Read the full press release